BAP1 mutations have been found in other aggressive cancers, including skin-derived melanomas, mesotheliomas, and renal cell carcinomas [12–17], suggesting a general role for BAP1 as a suppressor of metastasis in cancer. Here, BAP1 is linked to renal cell carcinoma.